Garg G - Search Results

1

Positive peritoneal cytology is an independent risk-factor in early stage endometrial cancer.

Garg G, Gao F, Wright JD, Hagemann AR, Mutch DG, Powell MA. Garg G, et al. Gynecol Oncol. 2013 Jan;128(1):77-82. doi: 10.1016/j.ygyno.2012.09.026. Epub 2012 Sep 29. Gynecol Oncol. 2013. PMID: 23032094 Free PMC article.

2

Evaluating the significance of location of lymph node metastasis and extranodal disease in women with stage IIIC endometrial cancer.

Garg G, Morris RT, Solomon L, Toy EP, Kruger M, Clary K, Munkarah A, Wright JD. Garg G, et al. Gynecol Oncol. 2011 Nov;123(2):208-13. doi: 10.1016/j.ygyno.2011.07.025. Epub 2011 Aug 6. Gynecol Oncol. 2011. PMID: 21821278

3

The risk of lymph node metastasis with positive peritoneal cytology in endometrial cancer.

Garg G, Gao F, Wright JD, Hagemann AR, Zighelboim I, Mutch DG, Powell MA. Garg G, et al. Int J Gynecol Cancer. 2013 Jan;23(1):90-7. doi: 10.1097/IGC.0b013e318275afd2. Int J Gynecol Cancer. 2013. PMID: 23196758 Free PMC article.

4

Intestinal perforation in gynecologic oncology: do all patients benefit from surgical management?

Garg G, Massad LS, Pourabolghasem S, Zhou G, Powell MA, Thaker PH, Hagemann AR, Wilkinson-Ryan I, Mutch DG. Garg G, et al. Gynecol Oncol. 2013 Jun;129(3):538-43. doi: 10.1016/j.ygyno.2013.03.004. Epub 2013 Mar 13. Gynecol Oncol. 2013. PMID: 23500088 Free PMC article.

5

Patterns of care, predictors, and outcomes of chemotherapy in elderly women with early-stage uterine carcinosarcoma: a population-based analysis.

Garg G, Yee C, Schwartz K, Mutch DG, Morris RT, Powell MA. Garg G, et al. Gynecol Oncol. 2014 May;133(2):242-9. doi: 10.1016/j.ygyno.2014.02.021. Epub 2014 Feb 19. Gynecol Oncol. 2014. PMID: 24561247 Free PMC article.

6

Stage IA vs. IB endometrial stromal sarcoma: does the new staging system predict survival?

Garg G, Shah JP, Toy EP, Bryant CS, Kumar S, Morris RT. Garg G, et al. Gynecol Oncol. 2010 Jul;118(1):8-13. doi: 10.1016/j.ygyno.2010.04.008. Epub 2010 May 5. Gynecol Oncol. 2010. PMID: 20447684

7

Novel treatment option for MUC16-positive malignancies with the targeted TRAIL-based fusion protein Meso-TR3.

Garg G, Gibbs J, Belt B, Powell MA, Mutch DG, Goedegebuure P, Collins L, Piwnica-Worms D, Hawkins WG, Spitzer D. Garg G, et al. BMC Cancer. 2014 Jan 21;14:35. doi: 10.1186/1471-2407-14-35. BMC Cancer. 2014. PMID: 24447304 Free PMC article.

8

Targeted metabolomic profiling of low and high grade serous epithelial ovarian cancer tissues: a pilot study.

Garg G, Yilmaz A, Kumar P, Turkoglu O, Mutch DG, Powell MA, Rosen B, Bahado-Singh RO, Graham SF. Garg G, et al. Metabolomics. 2018 Nov 24;14(12):154. doi: 10.1007/s11306-018-1448-3. Metabolomics. 2018. PMID: 30830441

9

Conjugation to a SMAC mimetic potentiates sigma-2 ligand induced tumor cell death in ovarian cancer.

Garg G, Vangveravong S, Zeng C, Collins L, Hornick M, Hashim Y, Piwnica-Worms D, Powell MA, Mutch DG, Mach RH, Hawkins WG, Spitzer D. Garg G, et al. Mol Cancer. 2014 Mar 7;13:50. doi: 10.1186/1476-4598-13-50. Mol Cancer. 2014. PMID: 24602489 Free PMC article.

10

Intra-operative detection of nodal metastasis in early stage cervical cancer: a survey of the practice patterns of SGO members.

Garg G, Shah JP, Toy EP, Field JB, Bryant CS, Liu JR, Morris RT. Garg G, et al. Gynecol Oncol. 2011 Apr;121(1):143-7. doi: 10.1016/j.ygyno.2010.12.337. Epub 2011 Jan 26. Gynecol Oncol. 2011. PMID: 21269668

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

470 results

Search Page

Filters